Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022

Derek Archila Downgraded (APLS) to Hold and Held Target at $58 on, Jan 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-58-on-jan-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Wells Fargo, Downgraded "Apellis Pharmaceuticals, Inc." (APLS) to Hold and Held Target at $58 on, Jan 3rd, 2023.

Derek has made no other calls on APLS in the last 4 months.



There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 3 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Thursday, November 10th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $43 on, Tuesday, November 8th, 2022
  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, September 12th, 2022


These are the ratings of the 3 analyists that currently disagree with Derek


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $79 on, Tuesday, November 15th, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $123 on, Tuesday, October 18th, 2022
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Thursday, September 8th, 2022

Publication Contributing Sources